To differentiate the features of two different drugs named as Nalbuphine and Buprenorphine when given along with Heavy Bupivacaine in the spinal route in planned surgical patients
Not Applicable
- Conditions
- Health Condition 1: 3- AdministrationHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2021/05/033520
- Lead Sponsor
- Sandhya K
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients acceptance
2.Patients aged above 20 and below 65 years
3.ASA status I and II patients
4.Patients undergoing elective infraumbilical surgeries under spinal anaesthesia
5.Surgeries involving lower abdomen, urological, gynaecological, orthopaedic and lower limb extremity
Exclusion Criteria
1.Patient denial
2.Absolute contraindications for spinal anaesthesia
3.Combined spinal epidural anaesthesia
4.Known hypersensitivity or allergy to study drugs
5.Pregnancy and lactating mothers
6.Morbid obesity (BMI >40)
7.Age below 20 years
8.Infection at the site of sub arachnoid block
9.Bleeding and coagulation disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method